JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2701
Grupo Aeroportuario del Pacifico
PAC
$12.4B
| $5M | ﹤0.01% |
25,636
+4,105
| +19% | +$745K |
2015 Q2
31 quarters
|
|
2702
CALL
S&P Global
SPGI
$117B
| $5M | ﹤0.01% |
14,500
-90,500
| -86% | -$31.9M |
2022 Q2
3 quarters
|
|
2703
Insmed
INSM
$23B
| $5M | ﹤0.01% |
292,889
-97,110
| -25% | -$1.89M |
2013 Q2
39 quarters
|
|
2704
U.S. High Relative Profitability Portfolio ETF Class Shares
DUHP
$12.9B
| $4.99M | ﹤0.01% |
198,605
+33,749
| +20% | +$835K |
2022 Q4
1 quarter
|
|
2705
Equitable Holdings
EQH
$14.9B
| $4.99M | ﹤0.01% |
196,515
-210,398
| -52% | -$6.21M |
2018 Q2
19 quarters
|
|
2706
CALL
CrowdStrike
CRWD
$286B
| $4.98M | ﹤0.01% |
+145,200
| New | +$4.2M |
2023 Q1
0 quarters
|
|
2707
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.58B
| $4.98M | ﹤0.01% |
42,559
+31,101
| +271% | +$3.62M |
2016 Q4
25 quarters
|
|
2708
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.59B
| $4.97M | ﹤0.01% |
74,071
+17,598
| +31% | +$1.18M |
2013 Q2
39 quarters
|
|
2709
NBT Bancorp
NBTB
$2.63B
| $4.96M | ﹤0.01% |
147,212
-100,090
| -40% | -$3.92M |
2013 Q2
39 quarters
|
|
2710
PUT
Sarepta Therapeutics
SRPT
$1.83B
| $4.96M | ﹤0.01% |
36,000
+28,500
| +380% | +$3.7M |
2022 Q3
2 quarters
|
|
|
FRXB
2711
DELISTED
Forest Road Acquisition Corp. II
FRXB
| $4.96M | ﹤0.01% |
+499,180
| New | +$5.02M |
2023 Q1
0 quarters
|
|
2712
Patria Investments
PAX
$1.81B
| $4.96M | ﹤0.01% |
335,206
+12,494
| +4% | +$190K |
2021 Q1
8 quarters
|
|
2713
AB Tax-Aware Short Duration Municipal ETF
TAFI
$1.35B
| $4.95M | ﹤0.01% |
+196,962
| New | +$4.94M |
2023 Q1
0 quarters
|
|
2714
CALL
Target
TGT
$70.1B
| $4.95M | ﹤0.01% |
29,900
-160,000
| -84% | -$26.3M |
2020 Q3
10 quarters
|
|
2715
Teladoc Health
TDOC
$1.05B
| $4.94M | ﹤0.01% |
190,872
-49,490
| -21% | -$1.32M |
2015 Q3
30 quarters
|
|
|
SVC
2716
Service Properties Trust
SVC
$841M
| $4.94M | ﹤0.01% |
99,229
+1,294
| +1% | +$59.8K |
2013 Q2
39 quarters
|
|
2717
Gentherm
THRM
$1.69B
| $4.94M | ﹤0.01% |
81,793
+17,552
| +27% | +$1.18M |
2014 Q3
34 quarters
|
|
2718
CALL
BioMarin Pharmaceuticals
BMRN
$10.9B
| $4.94M | ﹤0.01% |
50,800
-34,200
| -40% | -$3.55M |
2022 Q4
1 quarter
|
|
2719
TAL Education Group
TAL
$6.99B
| $4.94M | ﹤0.01% |
769,984
+614,448
| +395% | +$4.42M |
2013 Q2
39 quarters
|
|
2720
Global Net Lease
GNL
$1.88B
| $4.93M | ﹤0.01% |
383,184
-145,398
| -28% | -$2M |
2016 Q4
25 quarters
|
|
2721
SPX Corp
SPXC
$8.81B
| $4.93M | ﹤0.01% |
69,828
-14,870
| -18% | -$1.05M |
2013 Q2
39 quarters
|
|
|
APTV.PRA
2722
DELISTED
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
| $4.91M | ﹤0.01% |
40,000
-14,999
| -27% | -$1.84M |
2021 Q4
5 quarters
|
|
2723
Renasant Corp
RNST
$3.6B
| $4.9M | ﹤0.01% |
160,337
+77,657
| +94% | +$2.72M |
2016 Q4
25 quarters
|
|
2724
Dorman Products
DORM
$3.76B
| $4.9M | ﹤0.01% |
56,819
+14,175
| +33% | +$1.26M |
2015 Q4
29 quarters
|
|
2725
FB Financial Corp
FBK
$2.63B
| $4.9M | ﹤0.01% |
157,547
-16,963
| -10% | -$606K |
2016 Q4
25 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.